Stay updated with breaking news from Harvard Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bard Associates Inc. cut its position in shares of Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) by 1.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 293,297 shares of the medical instruments supplier’s stock after selling 5,000 shares during the period. […]
Analysts’ new coverage for Thursday, May 18th: StockNews.com initiated coverage on shares of Agilent Technologies (NYSE:A). The firm issued a buy rating on the stock. StockNews.com assumed coverage on shares of Alcoa (NYSE:AA). They issued a sell rating on the stock. StockNews.com began coverage on shares of American Airlines Group (NASDAQ:AAL). StockNews.com issued a buy […]
Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) was the recipient of a significant increase in short interest in April. As of April 30th, there was short interest totalling 348,800 shares, an increase of 28.1% from the April 15th total of 272,200 shares. Currently, 1.0% of the shares of the stock are sold short. Based on […]
Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) was the target of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 348,800 shares, a growth of 28.1% from the April 15th total of 272,200 shares. Based on an average daily trading volume, of 154,200 shares, […]
/PRNewswire/ -- The global laboratory analytical instruments and consumables market size is estimated to increase by USD 15.99 billion from 2022 to 2027. The...